Drug Type Small molecule drug |
Synonyms |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists), TGR5 agonists(G-protein coupled bile acid receptor 1 agonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Discovery | United States | - | |
Inflammatory Bowel Diseases | Discovery | United States | - | |
Nonalcoholic Steatohepatitis | Discovery | United States | - |